A group of federal health agencies said in a government publication that they want to study the various minority cannabinoids in marijuana, as well as cannabis terpenes, to determine how they can best be used to treat a handful of medical conditions. According to a notice issued by the National Institutes of Health, eight of the agency's affiliates want to fund research on medical marijuana. These studies will focus on cannabinoids such as CBD, CBN, CBG and delta-8 THC, rather than the well-known delta-9 THC (which is the main cannabinoid in cannabis that gets consumers high). Institutions promoting research include the National Center for Complementary and Integrative Health, the National Cancer Institute, the National Eye Institute, the National Institute on Aging, the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, the National Institute of Dental and Craniofacial Research, and the National Institute of Neurological Disorders and Stroke. Research on marijuana is limited because the plant remains illegal at the federal level. However, the U.S. House of Representatives recently passed a bipartisan bill that would make it easier for researchers to study marijuana.
Information source: mjbizdaily.com/